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Abstract: Despite successful control by vaccination, Marek’s disease (MD) has continued evolving 
to greater virulence over recent years. To control MD, selection and breeding of MD-resistant 
chickens might be a suitable option. MHC-congenic inbred chicken lines, 61 and 72, are highly 
resistant and susceptible to MD, respectively, but the cellular and genetic basis for these phenotypes 
is unknown. Marek’s disease virus (MDV) infects macrophages, B-cells, and activated T-cells in 
vivo. This study investigates the cellular basis of resistance to MD in vitro with the hypothesis that 
resistance is determined by cells active during the innate immune response. Chicken bone marrow-
derived macrophages from lines 61 and 72 were infected with MDV in vitro. Flow cytometry showed 
that a higher percentage of macrophages were infected in line 72 than in line 61. A transcriptomic 
study followed by in silico functional analysis of differentially expressed genes was then carried out 
between the two lines pre- and post-infection. Analysis supports the hypothesis that macrophages 
from susceptible and resistant chicken lines display a marked difference in their transcriptome 
following MDV infection. Resistance to infection, differential activation of biological pathways, and 
suppression of oncogenic potential are among host defense strategies identified in macrophages 
from resistant chickens. 
Keywords: chickens, Marek’s disease virus, disease resistance, macrophages, RNA-seq  
 
1. Introduction 
Marek’s disease (MD) is an oncogenic viral disease of chickens caused by the Gallid 
alphaherpesvirus 2, which is traditionally known as Marek’s disease virus (MDV). Gallid herpesvirus 2 
is part of the Alphaherpesvirinae subfamily in the genus Mardivirus. Losses incurred by the poultry 
industry due to the virus are considerable. Until now, effective vaccination has led to successful 
control of this disease, but as none of these vaccines can induce sterile immunity against MD, the 
virulence of MDV has been increasing over the years amid the introduction of new generations of 
vaccines [1]. This emphasizes the necessity for implementation of alternative control methods for 
MD. A suitable method could be the selection and breeding of MD-resistant chickens. The estimates 
of heritability of MD resistance are as high as 61% [2], suggesting good potential for genetic 
improvement for meat and egg production [3]. However, resistance to MD is multifaceted, as many 
features including host genetics, viral strain, and environmental factors constitutively regulate this 
mechanism.  
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In the host, various genes from within and without the MHC (Major Histocompatibility 
Complex) region are involved. Within the MHC, the C-type lectin-like receptor genes, B-NK and B-
lec have been considered as potential candidate genes for resistance to MD [4] and previous reports 
show that the C-type lectin-like receptors (Ly49H, NKR-P1, and Clr) in mouse and rat are associated 
with resistance to another herpesvirus, cytomegalovirus (CMV) [5,6]. Non-MHC genes also play a 
pivotal role in MD resistance. More than 20 separate QTL (quantitative trait loci) are involved [7–9]. 
This can be most clearly explained by studies from two inbred chicken lines (61 and 72), which are 
homozygous for the B2 haplotype [10]. Lines 61 and 72 are highly resistant and highly susceptible to 
clinical MD respectively, which is reflected by large differences in host viraemia levels when 
challenged with MDV [11,12], suggesting that resistance to MD is mostly exerted by the genes outside 
of the MHC. Several potential non-MHC candidate genes for MD-resistance or susceptibility have 
been identified in various cell types to date. These include TLR3 and IL6 in chick embryo fibroblasts 
[13], GH1 and Ly6E in splenocytes [14,15] and IRG1 in splenocytes [16]. Marek’s disease virus infects 
various lymphoid cells such as macrophages, B and T cells [17,18], as well as non-lymphoid cells such 
as fibroblasts [13], EACs (ellipsoid-associated cells) [19] in both in vivo and in vitro conditions, but it 
is still unclear at what stage of infection and in/or by which cells those resistance mechanisms or 
genes are expressed. 
Resistance to MD in the inbred lines 61 and 72, in terms of viral load, is established as early as 3 
dpi [16,20] and by this time the virus has infected phagocytic cells, B cells, and activated T cells [17]. 
Hence, the resistance mechanisms could be exerted in any or all of these cell types. The early events 
of differential viraemia [20] and gene expression profiles [16] in these two inbred lines suggest that 
the differences between the two lines are due to innate rather than adaptive host immune responses 
[21]. However, very little is known about the early stages of MDV infection. In order to explore the 
resistance phenotype in innate immune cells, bone marrow-derived macrophages (BMDMs) from 
lines 61 and 72 were infected with MDV using a newly developed in vitro MDV-phagocyte infection 
model [18]. Variation in gene expression is a major determinant of phenotypic variation and 
differences in MD genetic resistance are most likely due to variation in the transcriptional regulation 
of genes [22]. Therefore, RNA-seq and transcriptomic analysis were used to determine differentially 
expressed (DE) genes in the two chicken lines pre- and post-MDV infection of BMDMs. The aims of 
this study were to determine the resistance phenotype in macrophages from these two inbred chicken 
lines as well as to explore the biological pathways associated with resistance or susceptibility to MD.  
2. Materials and Methods 
2.1. Experimental Animals 
Inbred specific pathogen free (SPF) chickens from lines 61 and 72 were used in this study. Line 61 
birds were bred in the Poultry Production Unit at the Institute for Animal Health, Compton, UK and 
reared in the poultry unit of The Moredun Research Institute, while line 72 chickens were bred and 
reared at the National Avian Research Facility (NARF), Edinburgh, UK. For chicken embryos, chicken 
layer line J was used (an intercross bred from 9 lines, originally bred from Brown Leghorn chickens 
at the Poultry Research Centre, Edinburgh). They were bred and conventionally raised at the NARF 
(http://www.narf.ac.uk/chickens/lines).  
2.2. Marek’s Disease Virus 
The virus, CVI988 UL41 eGFP, was generated from a BAC construct of vaccine strain CVI988 
(Rispens) of MDV serotype 1, in which the UL41 gene was replaced with eGFP (enhanced Green 
Fluorescent Protein) under control of the murine phosphoglycerol kinase promoter [23]. UL41 is a 
non-essential gene for MDV replication and a UL41-deletant mutant replicates as well as the parental 
strain in vitro [24]. The presence of eGFP will therefore indicate MDV replication.  
2.3. Cell Cultures 
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Chicken embryo fibroblasts (CEFs) were cultured from 9–11-day-old chicken embryos in T175 
flasks at 38.5 °C with 5% CO2 in CEF medium consisting of M-199 medium (Gibco) containing 10% 
(v/v) tryptose phosphate broth (Invitrogen), 2.7% (v/v) NaHCO3 (Sigma–Aldrich), 1% (v/v) pen-strep 
(Sigma–Aldrich), 0.5% (v/v) gentamycin (Sigma–Aldrich), 0.001% (v/v) fungizone (amphotericin B, 
250 μg/mL) (Thermo Scientific), and 0.5–10% (v/v) fetal bovine serum (FBS) (Gibco) depending on 
CEF confluency in culture flasks. The MDV-BAC virus was initially grown and propagated in CEF 
cultures as previously described [25]. The MDV-infected CEFs were then grown in large numbers 
and pooled together to obtain a high virus titer. Pooled infected CEFs were resuspended in freezing 
media (FBS (PAA), RPMI-1640 (Sigma–Aldrich) and DMSO), aliquoted (250–500 μL/cryovial) and 
stored at −80 °C until further use. 
Chicken bone marrow cells were isolated from 3 to 6-week-old birds and BMDMs were cultured 
as described previously [26]. In order to obtain approximately 1 × 107 BMDMs at harvest, 4 day 
culture bone marrow (BM) cells were seeded at a concentration of approximately 1 × 106 cells/mL. 
Cells were cultured in T75 flasks at 41 °C with 5% CO2 using RPMI-1640 medium supplemented with 
10% heat-inactivated FBS, 1% L-glutamine and 0.1% pen-strep. Recombinant chicken colony 
stimulating factor 1 (chCSF-1) [26] was added to the BMDM cultures and medium was refreshed 
every 2 days.  
2.4. Co-Culture Infection Experiments and Fluorescence Activated Cell Sorting (FACS)  
Due to the cell-associated nature of MDV, infected CEFs were used to infect macrophages. On 
the day of macrophage infection, infected CEFs were harvested by treatment with 2.5% trypsin 
(diluted in PBS), pelleted by centrifugation (500 g for 5 min) and resuspended in FACS buffer (PBS 
and 1% BSA). In order to remove macrophages from the CEF culture, they were stained with anti-
CD45 (clone AV53, isotype IgG1, The Pirbright Institute) and a goat anti-mouse IgG1 conjugated with 
Alexa Fluor (AF) 647 as secondary antibody and Gr 13.1 as isotype control (ovine NKp46; kindly 
provided by Dr. Timothy Connelly, The Roslin Institute) according to the procedures described 
previously [27]. The GFP+ CD45- CEFs were sorted using the FACSAriaTM III cell sorter (BD 
Biosciences). Data were analyzed using FACSDiva v 6.1.3 software. 
The BMDMs were infected with 2 × 106 sorted infected CEF on day 4 of culture in T75 flasks at an 
infection ratio of 1:5 (CEF:BMDM) in RPMI-1640 medium containing 10% FBS (Gibco), 1% pen-strep, 
and 1% L-glutamine. Co-cultured cells were incubated at 41 °C with 5% CO2 for 1 day and harvested 
for downstream experiments. 
2.5. Flow Cytometry 
Cells were harvested with 100 mM EDTA in PBS, pelleted by centrifugation and resuspended in 
PBS containing 1% BSA and 0.1% sodium azide. Immunofluorescent staining was carried out using 
a monocyte/macrophage marker (clone KUL01, isotype IgG1, Southern Biotech) and anti-CD45. 
KUL01 was recently identified as a mannose receptor MCRL1B [28]. Cells were stained for flow 
cytometric analysis as described above and analyzed using a FACSCalibur (BD Biosciences). Viable 
cells were gated based on 7-AAD (7-aminoactinomycin D, Life Technologies) staining and the 
resulting data were analyzed with FlowJo software.  
2.6. Real-Time Quantitative RT-PCR 
Total RNAs were extracted using RNeasy Mini Kits (Qiagen). Cytokine mRNA expression levels 
were assessed using TaqMan real-time quantitative RT-PCR (qRT-PCR) by a well-described method 
[29,30] using 28S RNA as the reference gene [31]. Primers and probes used in this study for cytokines 
and 28S RNA-specific amplification are given in Table 1. The results are expressed as 40-Ct by 
deducting each Ct value from the total number of cycles (40). All data were checked for normality 
and pairwise statistical comparisons between means in two groups (control v infected, control v 
control, infected v infected) of the two inbred chicken lines (61 and 72) were carried out with a 2-
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Sample t-test (95% confidence interval) using Minitab 18 software (State College, USA). Statistical 
significance was determined as p < 0.05. 
Table 1. Primers and probes for TaqMan qRT-PCR. F: forward primer; R: reverse primer. 
RNA Target Probe/Primer Sequence (5'-3') 
28S 
Probe (FAM)-AGGACCGCTACGGACCTCCACCA-(TAMRA) 
F  GGCGAAGCCAGAGGAAACT 
R  GACGACCGATTTGCACGTC 
IL6 
Probe (FAM)-AGGAGAAATGCCTGACGAAGCTCTCCA-(TAMRA) 
F  GCTCGCCGGCTTCGA 
R  GGTAGGTCTGAAAGGCGAACAG 
IL18 
Probe (FAM)-CCGCGCCTTCAGCACGGATG-(TAMRA) 
F  AGGTGAAATCTGGCAGTGGAAT 
R  ACCTGGACGCTGAATGCAA 
 
2.7. Cells and Sample Preparation for RNA-sequencing (RNA-seq) 
The BMDMs from inbred chicken lines 61 and 72 were infected with pre-sorted MDV-infected 
CEFs at an infection ratio of 1:5 (CEF:BMDM) as described previously [18]. Upon infection, control 
and infected BMDMs were sorted on 1 dpi based on eGFP and CD45 expression. The RNAs were 
extracted using RNeasy Mini Kits (Qiagen, UK) and DNase treatment of RNAs was carried out with 
Ambion Turbo DNA-free kits (Life Technologies). The RNA quantification was performed using 
Qubit RNA Assay kit with the Qubit 2.0 Fluorometer (Invitrogen). Three separate biological 
replicates for each of the control and infected BMDMs were used for RNA preparation and 
subsequent sequencing. 
2.8. RNA-seq and Analysis 
RNA sequencing was performed by the Edinburgh Genomics sequencing facility (Edinburgh, 
UK) using a pool of individually barcoded RNA samples representing 3 biological replicates in each 
of the control and infected BMDMs. Paired-end sequencing was carried out on an Illumina HiSeq 
2500 using an Illumina TruSeq Rapid SBS Kit (Illumina, Little Chesterford, UK). The quality of the 
RNA-seq reads was evaluated using the software FastQC [32]. Adapter sequences (Illumina TruSeq 
v3 adapters) were trimmed from the FASTQ sequences using Cutadapt software [33] with a 
minimum length cut-off at 50 bp. Trimmed reads were analysed to explore the differentially 
expressed (DE) genes in MDV-infected and control BMDMs. The data analysis pipeline included the 
following steps: The short reads were aligned to the chicken genome sequence (Galgal4, Ensembl 
release 78) using Bowtie and TopHat software packages [34]. Following alignment of the RNA-seq 
reads, HTSeq-count was used to calculate counts per million (CPM) for each gene [35]. The 
differential gene expression was then analysed using edgeR (empirical analysis of digital gene 
expression in R) [36,37]. Differentially expressed genes were filtered using an FDR (False discovery 
rate) of 0.05 and fold change > 2. Viral transcript expression was measured by mapping reads to the 
CVI988 MDV genome (Accession: DQ530348) and counting reads using Kallisto 
(https://pachterlab.github.io/kallisto/). Sleuth (https://pachterlab.github.io/sleuth/) was then used to 
measure differential expression between lines. Expression is detailed as transcripts per million (TPM) 
values. 
2.9. Functional Analysis of DE Genes 
Significant DEGs (p < 0.05) were submitted to the DAVID (Database for Annotation, 
Visualization and Integrated Discovery) software package (version 6.7) (http://david.abcc. 
ncifcrf.gov/) to identify enriched gene ontology terms associated with genes expressed during the 
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host response in each line of birds. The analysis classification stringency was set to a high level and 
FDR for multiple testing was performed by the Benjamini and Hochberg method invoked within 
DAVID [38]. The enrichment score was calculated with a set of input genes highly associated with 
certain biological terms, which was statistically measured by a Fisher Exact test in the DAVID system 
(p < 0.05). The overall enrichment score for the group is based on the p-value of each term member.  
To determine which biological pathways are associated with DEGs identified pre- and post-
MDV infection in each line, the Pathway Express software within the Onto-Tools suite was used [39]. 
Genes differentially expressed in the control and MDV-infected macrophages (p < 0.05) were 
analyzed against a reference list of genes based on Galgal4 (Ensembl release 78). Annotation is based 
upon the equivalent human genes. In this program, the analysis displays up- and downregulated 
genes on KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways. The impact factor analysis 
includes the classical statistics as well as other crucial factors such as the magnitude of each gene’s 
expression change and its type, position, and interaction in the given pathways. Significance is 
determined using the FDR-corrected gamma p-value (<0.05), which is determined based on the 
impact analysis of each gene’s expression and interactions in a given pathway. Gene networks 
involved in a particular experimental condition are established using pathway diagrams. 
iPathwayGuide v1.2 (https://www.advaitabio.com/ipathwayguide.html) was also used to show 
genes up- and downregulated in significant pathways. This software analysis tool implements the 
“Impact Analysis” approach that takes into consideration the direction and type of all signals on a 
pathway, the position, role, and type of every gene, etc., as described above. The Ingenuity Pathway 
Analysis (IPA) program (Ingenuity Systems, http://www.ingenuity.com/) was used to reveal which 
canonical pathways (see Supplementary Materials, Figure S1) and biological functions (see 
Supplementary Materials, Figure S2) are inherently active in the control BMDMs between the two 
lines and which are switched on following MDV infection in the host. The p-value was calculated 
using the right-tailed Fisher Exact Test (threshold p < 0.05). 
Genes uniquely expressed in macrophages of the resistant (61) and susceptible (72) lines during 
the host response were analyzed for enriched biological pathways and transcription factor binding 
sites using the Expander (v7.11) software package (http://acgt.cs.tau.ac.il/expander/expander.html). 
The enrichment of transcription factor binding sites (TFBS) was carried out by using the PRIMA 
algorithm, included within the Expander package. Significance was determined as Bonferroni 
corrected p-values lower than 1 × 10−4. 
2.10. Determining MDV Quantitative Trait Loci (QTL) Candidate Genes 
The BioMart data mining tool within the Ensembl database (release 78) 
(http://www.ensembl.org/index.html) was used to identify genes located in genomic regions 
previously identified (see Supplementary Materials, Table S1) as being under QTLs for MDV 
resistance [7–9].  
3. Results 
3.1. Infection of Macrophages from Susceptible and Resistant Birds 
Chicken BMDMs from lines 61 and 72 were co-cultured with pre-sorted MDV-infected CD45- 
GFP+ CEFs at the same ratios (1:5) as described previously [18]. Flow cytometric characterization of 
BMDMs with KUL01 and CD45 staining at 1 dpi revealed that the proportion of infected 
macrophages was around three times higher in line 72 (34–38%), which is susceptible to MDV, than 
in line 61 (11–12%), which is resistant to MDV infection (Figure 1a). Co-culture cell sorting 
experiments also revealed similar differences between the infected BMDMs of the two inbred lines 
(Figure 1b).  
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Figure 1. (a) The in vitro infection of macrophages from two inbred lines with Marek’s disease virus 
(MDV). Chicken bone marrow-derived macrophages (BMDMs) from lines 61 and 72 were cultured 
with Colony stimulating factor 1 (CSF-1) for 4 days. On the day of infection, pre-sorted eGFP+ CD45- 
chick embryo fibroblasts (CEF)s were co-cultured with BMDMs at a ratio of 1:5 (CEF:BMDM). After 1 
day in culture, flow cytometric characterization of in vitro-infected BMDMs was performed for the 
surface expression of KUL01 and CD45. Data shown are representative of three independent 
experiments. Distribution of cells: Q1, infected CEFs; Q2, infected BMDMs; Q3, uninfected CEFs; Q4, 
uninfected BMDMs. Panel A and B: staining with isotype control for line 61 and 72; Panel C and D: 
staining with KUL01 for line 61 and 72; Panel E and F: staining with CD45 for line 61 and 72. (b) Graph 
showing means and the respective standard error of mean (SEM) of the percentages of infected cells 
found within the three biological replicates from lines 61 and 72 BMDM during cell sorting 
experiments. 
3.2. Pro-Inflammatory Cytokine Expression 
The mRNA expression levels of two pro-inflammatory cytokines, IL6 and IL18, were measured 
at 1 dpi between flow sort purified MDV-infected and control BMDM from the two inbred lines using 
TaqMan qRT-PCR. In general, the expression levels of the two cytokines were lower in line 72 BMDM 
following MDV infection compared to line 61 (Figure 2). There was no statistically significant 
difference in the mean IL6 mRNA expression in any of the BMDM groups from the two inbred lines. 
The overall expression of IL18 mRNA was significantly lower in infected BMDM than that of controls 
in each line. Although there was no significant difference in inherent IL18 levels between the two 
lines, the expression of IL18 was seen to be decreased significantly (p < 0.05) in the susceptible line 
(72) compared to the resistant line (61) following MDV infection (Figure 2).   
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Figure 2. Quantification of pro-inflammatory cytokines by qRT-PCR. The mRNA expression levels 
of IL6 and IL18 between control and flow sort purified infected BMDMs of lines 61 and 72 were 
measured on 1 dpi. Pairwise statistical comparisons between means in two groups (n = 3 in each 
group) of the two inbred chicken lines were carried out with a two-sample t-test (95% confidence 
interval) using Minitab 18 software. Con = control; In = infected. Means that share the same letter are 
significantly different (p < 0.05). 
3.3. Analysis of Gene Expression in Susceptible and Resistant Lines 
Analysis of RNA-seq data was carried out to explore differences in gene expression in control 
and infected BMDMs from two inbred lines. The infected BMDMs were purified using flow sorting 
based on expression of eGFP-MDV and CD45. Comparisons were made as follows: 1) control BMDM 
(line 61) v control BMDM (line 72) to see which genes are inherently differentially expressed between 
susceptible and resistant birds; 2) control BMDM v infected BMDM to define the host response to 
infection in each line of birds; 3) (infected BMDM — control BMDM) from line 61 v (infected BMDM 
— control BMDM) from line 72 to examine differences in host response to MDV infection between 
susceptible and resistant birds. The numbers of genes with a fold change >2 (FDR < 0.05) used for 
downstream functional analyses are provided in Table 2. The full lists of DEGs in BMDMs from lines 
61 and 72 are provided in Supplementary Materials, Table S2. 
Table 2. The numbers of differentially expressed (DE) genes (p < 0.05; fold change > 2) used for functional 
analysis. 
Category 
Genes more highly expressed 
in line 61 compared to line 72 
Genes more highly expressed 
in line 72 compared to line 61 
Host response in line 72 / 1394↓ and 1133↑ 
Host response in line 61 786↓ and 479↑ / 
Inherent difference 
between lines 
360 729 
Difference between 
lines upon infection 
401 555 
3.4. Inherent Differences in Gene Expression between the Two Lines  
Differences in gene expression were observed between the two lines even before infection (360 
DE genes in line 61 and 729 DE genes in line 72) (see Supplementary Materials, Table S2). Several 
genes that are known to be involved in the innate immune response were more highly expressed in 
the resistant line (61) than in the susceptible line (72). These included interferon regulatory factors 
(IRF1, IRF6); tumor necrosis factor alpha-induced proteins (TNFAIP2, TNFAIP6), TNF receptor 
associated factor and its interacting protein (TRAF2, TRAF3IP2); chemokine and chemokine receptor 
Genes 2019, 10, 74 8 of 17 
 
(CXCL14, CCR2); interferon induced transmembrane protein (IFITM3); and the myxovirus resistance 
gene (MX1). Conversely, DE genes with known immune function highly expressed in line 72 included 
a member of the TNF superfamily (TNFSF15), interleukin and interleukin receptors (IL1β, IL17RE, 
IL17RC). Thus, we show the inherent differences in the expression of immune genes existing between 
the two lines.  
3.5. Host Response to MDV Infection in Resistant and Susceptible Lines 
A total of 479 genes were upregulated and 786 genes were downregulated in the MD-resistant 
line (61) following MDV infection (see Supplementary Materials, Table S2). Few genes with known 
immune function were upregulated. Those that were, included a Tumour necrosis factor (TNF) 
superfamily member (TNFSF13B) and the suppressor of cytokine signaling gene (SOCS7). On the 
other hand, a number of immune related genes were downregulated in this line, such as TNF proteins 
and a TNF super family member (TNFAIP3, TNFAIP6, TNFRSF6B); Toll-like receptor (TLR15); 
chemokine and chemokine receptors (CXCL13L2, CCR5, CXCR4); interleukins and interleukin 
receptors (IL4I1, IL12B, IL13RA2, IL21R, IL22RA2); immunoglobulin superfamily member (IGSF1); 
janus–kinase gene (JAK3) and the lysozyme gene (LYZ). 
In the MD-susceptible line (72), 1133 genes were upregulated, and 1394 genes were 
downregulated after infection (see Supplementary Materials, Table S2). Genes with high expression 
levels included several chemokines and chemokine receptor (CCL1, CCL4, CCL20, CX3CL1, CCR7); 
interleukin and interleukin receptors (IL2RA, IL8L1, IL20RA, IL23R); TNFs (TNFAIP2, TNFRSF4, 
TRAF1, TRAF3, TRAF5, TRAF3IP2); genes involved in controlling the interferon response (IFITM3, 
IFITM5, IRF1, IRF4, IRF6, IRF10, STAT1, STAT2, STAT4, BATF); inducible nitric oxide synthase 
(INOS); IGSF3 and nuclear factor kappa B subunit 2 gene (NFKB2). Downregulated genes in this line 
included some interleukins and interleukin receptor (IL8, IL15, IL2RG); interferon receptors and 
interferon controlling genes (IFNAR1, IFNAR2, SOCS2, SOCS3, SOCS5); TNFSF15 and the avidin 
gene (AVD). 
3.6. Differences in Host Response between the Two Lines Following MDV Infection 
Differences in gene expression levels were identified between MDV-infected BMDMs from the 
two lines (401 DEGs were highly expressed in line 61 compared to line 72 and 555 DE genes were 
expressed at a higher level in line 72 than in line 61) (see Supplementary Materials, Table S2). Only a 
few immune genes were highly expressed in the resistant line (61) compared to the susceptible line 
(72). These included TNFSF11, CXXC5, IL15, MX1, and LY6E. In contrast, a number of chemokines 
and chemokine receptor (CCL20, CX3CL1, CXCL13L2, CCR7); interleukin and interleukin receptors 
(IL8L1, IL1R2, IL2RA, IL17RE, IL20RA, IL23R); and some other immune related genes (STAT2, STAT4, 
IGSF3, BATF3, AMIGO2, LYZ) were more highly expressed in the susceptible line (72). Therefore, 
MDV infection is seen to drive differential upregulation of immune genes between resistant and 
susceptible lines. 
3.7. Viral Gene Expression 
Viral gene expression after infection in lines 61 and 72 was determined and is presented in 
Supplementary Materials, Table S3. The small number of reads seen in control samples are 
background. A high level of viral expression is seen in the infected samples. Differences in expression 
of the viral genes in each of the two lines is shown in Supplementary Materials, Table S4. Viral 
transcripts are found to be present at up to three times higher levels in line 72 as compared to line 61. 
3.8. Gene Ontology Analysis of Differentially Expressed (DE) Genes 
Gene ontology analysis of DE genes was performed in order to understand the biological 
processes involved in BMDMs of resistant (61) and susceptible (72) birds following MDV infection. In 
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line 61, genes clustered into the following ontologies: carbohydrate binding, glycosylation, cell 
adhesion, and cell communication; whereas in line 72 genes were associated with immune cell 
activation/differentiation, cytokine binding and signal transduction (see Supplementary Materials, 
Tables S5 and S6).  
3.9. Functional Analysis Reveals Significantly Regulated Biological Pathways  
The DE genes were analyzed using iPathwayGuide to determine the biological pathway(s) 
altered during the host response following MDV infection in each line. In the resistant line (61), focal 
adhesion was the most significantly altered biological pathway; whereas the cytokine–cytokine 
receptor interaction pathway was significantly perturbed in the susceptible line (72). Figures 3a and 
3b show the genes with altered expression patterns in the given biological pathway in BMDMs of 
lines 61 and 72, respectively. 
Figure 3. Differentially expressed genes in pathways responding to MDV infection as identified by 
iPathwayGuide. Up- and downregulated genes in (A) MD-resistant line 61 and in (B) MD-susceptible 
line 72 BMDMs are associated with focal adhesion and cytokine–cytokine receptor interaction 
pathways, respectively. Blue = upregulated; red = downregulated. 
Complementary to the findings from iPathwayGuide, use of the ingenuity pathway analysis (IPA) 
program revealed which canonical pathways were differentially regulated during MDV infection in 
BMDMs from each line (Figure 4). A higher response was seen in the resistant line (61) for ILK 
signaling, iNOS signaling, coagulation, complement and TNFR signaling; while in the susceptible 
line (72) a higher response was observed for IL8, ERK5, B-cell receptor (BCR) and IL6 signaling. 
Likewise, in line 61 LXR/RXR activation and p53 signaling are lower than in line 72, with PPAR 
signaling and sirtuin signaling lower in line 72 than in line 61. 
Enriched gene ontology functional annotation was determined using the Expander program. 
Over-represented transcription factor binding sites (TSBFs) were also determined using this software. 
A set of genes downregulated only in line 61 after MDV infection (see Supplementary Materials, Table 
S7) were seen to be involved with TLR signaling and JAK-STAT signaling pathways (Figure 5a). Both 
TLR and JAK-STAT signaling are important cellular pathways most likely to be involved in the innate 
immune response [16]. A substantial number of these genes had ZNF42 (zinc finger protein 42) 
transcription factor (TF) binding sites in their promoter regions (Figure 5b). The ZNF42 protein, also 
known as MZF1 (myloid zinc finger 1), is a putative oncogenic protein [40]. On the other hand, line 
72 had upregulated expression of a different set of genes (see Supplementary Materials, Table S8) 
which were seen to be associated with cytokine–cytokine receptor interactions (Figure 5c) which is 
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also an important pathway involved in innate immunity [16]. No specific enrichment of TF binding 
sites was identified in this line.  
Figure 4. Functional analysis of DE genes using IPA (ingenuity pathway analysis). IPA showing the 
comparison of the most highly represented canonical pathways due to MDV infection in line 61 and 
line 72 BMDMs. MAC= macrophage; HR=host response. 
 
Figure 5. Over-representation analysis of genes with their involvement in biological processes as 
determined by Expander software. (a) The GO (gene ontology) processes involved with genes 
downregulated only in line 61 infected BMDM and (c) the GO process involved with genes 
upregulated only in line 72 infected BMDM. The frequency of genes of a functional class within the 
examined set is described as a percentage of the total. (b) Significantly enriched ZNF42 transcription 
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factor (TF) binding sites in genes downregulated in line 61 infected BMDM. The frequency ratio 
(frequency of the set divided by the frequency of the background) was 1.24, which means presence 
of 1.24 times as many ZNF42 sites than would be expected by chance. 
3.10. Identification of Putative Candidate Genes for Resistance to MDV 
By analyzing genes showing high levels of differential regulation after MDV infection (or 
differential inherent expression between lines) and mapping them to regions underlying known QTL, 
we were able to highlight potential candidate genes for resistance to MDV infection (Supplementary 
Materials, Table S9). These include the tumor suppressor gene, RASEF (expressed only during the 
line 61 host response) and a gene involved in regulating cell-mediated immunity, HHLA2 (highly 
expressed in line 72 following infection). Inherent expression differences were also observed between 
the two lines such as that of a gene involved in formation of tight junctions (CLDN5). Several immune-
related genes show different basal levels of gene expression. These include CHGA (also associated 
with neuroendocrine tumors), CFH, SPP1, and an immunoglobulin-like receptor. Genes with 
neuronal association (SLC5A7, PAX6, NTN4L) were seen to be upregulated in line 61, while a gene 
associated with lymphoma and leukemia (CD72) was highly expressed in line 72. 
4. Discussion 
In order to explore the cellular basis of resistance to MD, BMDMs from two inbred chicken lines 
(61 and 72) were infected with MDV-infected CEF using a newly developed infection model and 
subsequently characterized by flow cytometry, qRT-PCR and RNA-seq on 1 dpi. Herpesviruses 
commonly infect and replicate in epithelial cells prior to infection of leukocytes. Chick embryo 
fibroblasts are comprised of a variety of cells types and hence infection with CEF-derived MDV likely 
represents the in vivo infection. The chicken inbred lines 61 and 72 are highly resistant and susceptible 
to MD, respectively, although they share the same MHC. Mortality rates by MD range from 7 to 94 
per cent in resistant and susceptible chickens, respectively [21].  
Pathologically the disease is manifested by T cell latency in resistant birds and by latency as well 
as lymphomatosis in susceptible birds. The two inbred lines (61 and 72) show differences in viraemia 
level (10-fold higher virus titre in susceptible compared to resistant birds) and gene expression 
profiles in splenocytes from the very early stages of MDV infection [11,16], suggesting that the 
inherent difference between the two lines is due to innate rather than the adaptive immune responses 
[21]. The cells of the innate immune system, especially macrophages, play a crucial role during MDV 
infection. For example, peritoneal macrophages isolated from MDV-infected chickens inhibit the 
formation of MDV plaques in vitro [41]. Peritoneal macrophages also show more phagocytic and 
plaque-inhibiting activity following MDV infection in susceptible birds compared to resistant 
chickens [42]. Macrophages from outbred chickens were shown to become infected in vitro in our 
previous study [18]. In the present study, BMDMs from MHC-congenic MD-resistant (61) and 
susceptible (72) inbred chickens were infected with MDV in vitro in the first study of its kind. The 
overall flow cytometric results revealed that with a fixed infection ratio, a higher proportion of 
BMDMs were infected from the susceptible line (72) compared to the resistant line (61). This might be 
an indication that macrophages play a significant role in exerting resistance to MDV in line 61. 
Marek’s disease virus infection results in latency in resistant chicken lines in which the virus remains 
undetectable by the immune system [29]. In the present study, a low infection rate of BMDMs by 
MDV in the resistant line supports this hypothesis. Differential susceptibility or resistance between 
MHC-congenic chicken lines was also reported in the infection of macrophages with ILTV (infectious 
laryngotracheitis virus), another alpha-herpesvirus [43]. Macrophages are thought to inhibit MDV 
replication as they release NO (nitric oxide) through the increased activity of iNOS. An upregulation 
of iNOS pathway was revealed in this study in BMDMs of the resistant line during functional analysis 
of DE genes. This suggests a very rapid induction of the NO activity in BMDMs of the resistant line 
at 1 dpi. Nitric oxide is thought to be crucial for inhibiting MDV replication during the cytolylic and 
latent phases of infection in vivo, because an increased level of NO was observed in splenocyte 
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cultures of MDV-infected resistant chickens [44]. Our study suggests that NO not only plays a role 
during the cytolytic and latent phases but may also act during the pre-cytolytic or entry phase of 
MDV infection.  
The mRNA expression levels of two pro-inflammatory cytokines, IL6 and IL18, in control and 
infected BMDMs from two inbred line, were measured in this study. In a previous in vivo MDV 
infection study [29], IL6 and IL18 were reported to be crucial factors in determining resistance or 
susceptibility to MD, as both cytokines were found to be upregulated in the splenocytes of susceptible 
birds (lines 72 and P), but not in resistant chickens (lines 61 and N). In partial agreement with the 
previous study, no significant expression of IL6 was observed here in BMDMs of the resistant line, 
but this was the case in the susceptible line as well. An elevated expression of pro-inflammatory 
cytokines during the cytolytic phase is most likely related to increased pathology in susceptible 
chickens [29] which also correlates with another study where a higher expression of IL18 was 
reported in caecal tonsils of susceptible chickens (line 72) compared to resistant chickens (line 63) [45]. 
In contrast, a significantly lower expression of IL18 was measured in our study in BMDMs of the 
susceptible line following MDV infection. Macrophages, monocytes, and dendritic cells all express 
IL18 [29] and one of the main roles of this cytokine is to enhance the activity of NK (natural killer) 
cells [46]. A lower NK cytotoxicity was detected previously in MD-susceptible compared to MD-
resistant chickens [47,48]. In the present study, a reduced expression of IL18 in MDV-infected 
BMDMs of the susceptible line might lead to decreased NK cell activity which in turn may play a role 
in formation of lymphomas in these birds, as a higher NK activity is more likely to be involved in 
antitumor responses [29]. 
An RNA-seq analysis of MDV-infected innate immune cells in vitro has not previously been 
carried out. To characterize the innate immune response to MDV infection, DE genes from control 
and infected BMDMs from both resistant and susceptible lines were analyzed and compared in this 
study. It was previously stated [16] that the resistance mechanism to MD in line 61 birds could be due 
to the higher expression of key immune genes compared to that of line 72 which in turn restricts 
disease progression in these chickens. In the present study, a higher level of immune gene expression 
was identified inherently in the BMDMs from the resistant line compared to that of the susceptible 
line, and differential gene expression was observed during macrophage responses between the two 
lines following MDV infection such as various interleukins, chemokines and their receptors being 
downregulated in the BMDMs from line 61 while the opposite occurred in line 72, suggesting the virus 
remains undetected by the immune system of resistant birds. This is in agreement with the statement 
that MDV persuades latency in resistant chickens where it is mostly not recognized by the host 
immune responses [29]. 
In our study, it was seen that genes involved in immune pathways such as TLR and JAK-STAT 
signaling were downregulated in BMDMs of line 61 (resistant) during MDV infection. An important 
cellular pathway involved in the innate immune response is the JAK-STAT pathway [16] and it may 
have a role in the genetic basis of MD resistance [49,50]. A transcriptional upregulation of JAK-STAT 
and MAPK pathways was observed in MDV-infected CEFs of the same susceptible line but not in the 
resistant line, suggesting a role for these pathways in the expression of genes involved in cell survival 
and proliferation which might lead to MDV-induced transformation of cells in susceptible lines [51]. 
An activated JAK-STAT pathway is involved in cell survival and proliferation by nuclear 
translocation of an activated STAT dimer which results in transcription of genes involved in these 
processes [52]. In the present study, downregulation of the JAK-STAT pathway could therefore be a 
strategy of host cells (BMDMs of the resistant line) to induce cell death and subsequent restriction of 
virus transmission from cell-to-cell. Marek’s disease virus is strictly cell-associated, and no infectivity 
of virus is found outside the cell under in vitro conditions, suggesting cell-to-cell transmission of 
infectious virus particles [53]. Moreover, cellular projections between macrophages were observed 
by time-lapse confocal microscopy in our previous in vitro study [18], with these projections most 
likely being actin microfilaments [54]. Interestingly, TLR4-linked JAK2 signaling contributes to 
rearrangement of the cellular cytoskeleton (F-actin) during internalization of an intracellular 
microorganism, Brucella abortus, by BMDM in mice [55]. It can, therefore, be hypothesized that 
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inactivation of such immune pathways in macrophages of MD-resistant chickens might lead to 
interruption of actin-mediated spread of MDV between cells which in turn results in limiting MDV 
infection in this line. However, further studies are needed to clarify this. 
Downregulated genes expressed only in line 61 infected BMDMs had significantly enriched 
ZNF42 TF binding sites in their promoter region. This transcription factor, commonly known as 
myeloid zinc finger protein 1 (MZF1), is a zinc finger TF preferentially expressed in hematopoietic 
stem cells, myeloid progenitor cells, and in differentiated myeloid cells [56,57]. Several reports 
suggest MZF1 as a putative tumorigenic protein [40,58]. To date, the role of MZF1 TF binding sites in 
genes downregulated during MDV infection has not been evaluated. However, an enrichment of 
HIC1 (hyper-methylated in cancer 1, a tumor-suppressor) binding sites was observed in the genes 
downregulated in MDV-infected splenocytes at 4 dpi in a previous study [16], and hence the authors 
suggested that MDV infection could block an anti-tumor mechanism long before the MDV oncogene 
(Meq) is expressed. In the present study, we see over-representation of TFBS for the putatively 
oncogenic MZF1 protein in genes downregulated after infection of resistant line 61 BMDMs. This TF 
binding site was detected in genes downregulated during the host response in the MD-resistant line 
(61) at 1 dpi, but not in the susceptible line (72). This again appears to confirm that the resistant birds 
are able to suppress potential tumorigenic activity at an early stage post-infection. In addition, 
transcriptional repression by MZF-1 requires FHL3 (four and a half LIM domain protein 3) as a 
cofactor [59] and FHL3 can also recruit a C-type binding protein (CtBP) as a co-repressor by which 
they regulate gene expression [60]. The interaction of CtBP with oncogene Meq plays a crucial role in 
MDV-induced lymphomas [61] and it was also speculated that by recruiting CtBP and its co-
repressors, Meq might function in tumorigenesis and/or the establishment of latency in T cells [61]. 
MDV induces T cell latency in resistant lines, whereas it induces latency and lymphoma formation in 
susceptible birds. Although MDV transforms lymphocytes during its life cycle, the downregulation 
of macrophage genes with MZF1 binding sites might have an influence on tumorigenesis when the 
infection transmits from macrophages to lymphocytes. Moreover, the Meq oncoprotein of the MDV 
vaccine strain (CVI988), which was used in this study, is unable to induce lymphoma as it has a 178 
bp insertion which significantly diminishes its transactivation properties of this strain [62]. Therefore, 
further studies will be required to explore the exact role of MZF1 in MD resistance.  
Mapping DE genes located under known MDV QTL regions revealed putative candidate genes 
for MD resistance or susceptibility in both pre- and post-infection conditions. A gene involved in 
formation of tight junctions showed inherent upregulation in resistant line 61 BMDMs (CLDN5), 
whereas CD72, which is involved in lymphoma of the small intestine, was highly expressed in MD-
susceptible chickens. How tight junctions are regulated in macrophages of resistant chickens may be 
part of a mechanism by which cell-to-cell spread of virus is restricted in this line during infection [16]. 
A known tumor-suppressor gene, RASEF [63,64], was seen to be exclusively expressed in MDV-
infected BMDMs of line 61. The HHLA2 gene, however, was highly expressed in BMDMs of MD-
susceptible line 72, which presumably implicates it in a novel immunosuppressive mechanism within 
the microenvironment of metastatic disease [65]. The ability of the resistant birds to suppress 
potential tumorigenic activity along with the expression of tumor-suppressor genes might be crucial 
in determining resistance to MD. However, no report of these genes has yet been published in relation 
to MD. Therefore, it will be interesting to explore their tentative role(s) in MD resistance or 
susceptibility in future studies. 
5. Conclusions 
Taken together, the data generated in this study support the hypothesis that resistance to MDV 
is most likely determined at the very early stage of infection during the innate immune response, 
with resistance mechanisms being deployed during early infection of macrophages. Many early 
defense methods are in play, such as the lessened ability of the virus to infect the resistant line 
compared to the susceptible line; differences in inherent gene expression between the two lines, 
resulting in differential host responses following infection, also promote resistance. Early anti-tumor 
mechanisms in the resistant line add to the strategies deployed by the host to fend off the effects of 
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viral infection. We also highlight putative candidate genes for conferring resistance to MDV infection 
in macrophages. 
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MAC_inherent_pathways; Figure S2. MAC_inherent_biofunctions. 
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